Fosun International’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,166	Closed	-$1.31M	–	287
2019 Q2	$1.31M	Buy	8,166 +1,120	+16%	+$180K	0.09%	139
2019 Q1	$1.4M	Buy	7,046 +3,160	+81%	+$628K	0.09%	129
2018 Q4	$778K	Buy	+3,886	New	+$778K	0.05%	172